<?xml version="1.0" encoding="utf-8" standalone="no"?>
<!DOCTYPE file
  SYSTEM 'wikixml.dtd'>
<file type="Article" date="2025-07-19T01:38:10Z" sourceCorpus="COVID-19" filename="69577119" title="KD-414" url="https://en.wikipedia.org/wiki/KD-414">
	<text>
		<segment id="id69577119">KD-414 is a COVID-19 vaccine candidate developed by Japanese biotechnology company KM Biologics Co. Results of a phase 1/2 clinical trial for this vaccine were released as a preprint in June 2022.

 References 













</segment>
	</text>
</file>
